Dr Lal PathLabs Overview
- Year Founded
-
1949
- Status
-
Public
- Employees
-
5,611
- Stock Symbol
-
LALPATHLAB
- Investments
-
15
- Share Price
-
$21.23
- (As of Monday Closing)
Dr Lal PathLabs General Information
Description
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
Contact Information
Website
www.lalpathlabs.comCorporate Office
- 12th Floor, Tower B, SAS Tower
- Medicity, Sector-38
- Gurgaon, Haryana 122001
- India
Corporate Office
- 12th Floor, Tower B, SAS Tower
- Medicity, Sector-38
- Gurgaon, Haryana 122001
- India
Dr Lal PathLabs Stock Performance
As of 16-Nov-2026, Dr Lal PathLabs’s stock price is $21.23. Its current market cap is $3.55B with 167M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $21.23 | $21.19 | $13.58 - $22.14 | $3.55B | 167M | 285K | $0.38 |
Dr Lal PathLabs Financials Summary
As of 30-Sep-2026, Dr Lal PathLabs has a trailing 12-month revenue of $327M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 3,344,691 | 2,190,197 | 2,302,711 | 2,185,991 |
| Revenue | 327,236 | 312,658 | 291,072 | 268,947 |
| EBITDA | 105,502 | 89,027 | 85,453 | 75,252 |
| Net Income | 62,932 | 57,125 | 57,610 | 43,212 |
| Total Assets | 359,975 | 333,430 | 317,607 | 294,503 |
| Total Debt | 23,248 | 21,090 | 18,404 | 29,610 |
Dr Lal PathLabs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dr Lal PathLabs Comparisons
Industry
Financing
Details
Dr Lal PathLabs Competitors (10)
One of Dr Lal PathLabs’s 10 competitors is Metropolis Healthcare, a Formerly PE-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Metropolis Healthcare | Formerly PE-Backed | Mumbai, India | ||||
| Thyrocare Technologies | Formerly PE-Backed | Navi Mumbai, India | ||||
| Oncquest | Corporation | Gurugram, India | ||||
| Prognosis Laboratories | Corporate Backed or Acquired | New Delhi, India | ||||
| Aspira Pathlab & Diagnostics | Corporation | Navi Mumbai, India |
Dr Lal PathLabs Signals
Dr Lal PathLabs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Dr Lal PathLabs Investments & Acquisitions (15)
Dr Lal PathLabs’s most recent deal was a Merger/Acquisition with SN Genelab for . The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SN Genelab | 01-Oct-2026 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Sunshine Healthcare | 26-Sep-2026 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Shahbazkers Diagnostic Centre | 01-May-2026 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Dr Lal PathLabs (Four Unit Property in New Delhi, India) | 23-Sep-2025 | Corporate Asset Purchase | Buildings and Property | ||
| Suburban Diagnostics | 26-Oct-2021 | Merger/Acquisition | Laboratory Services (Healthcare) |
Dr Lal PathLabs ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
17.47 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Services
Subindustry
of 97
Rank
Percentile
Dr Lal PathLabs Exits (1)
Dr Lal PathLabs’s most recent exit was on 26-Oct-2021 from Suburban Diagnostics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Suburban Diagnostics | 26-Oct-2021 | Completed |
|
Dr Lal PathLabs Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sunshine Healthcare | Accra, Ghana | 2010 | |
| SN Genelab | Surat, India | 1993 | |
| Shahbazkers Diagnostic Centre | Mumbai, India | 1980 |
Dr Lal PathLabs FAQs
-
When was Dr Lal PathLabs founded?
Dr Lal PathLabs was founded in 1949.
-
Where is Dr Lal PathLabs headquartered?
Dr Lal PathLabs is headquartered in Gurgaon, India.
-
What is the size of Dr Lal PathLabs?
Dr Lal PathLabs has 5,611 total employees.
-
What industry is Dr Lal PathLabs in?
Dr Lal PathLabs’s primary industry is Laboratory Services (Healthcare).
-
Is Dr Lal PathLabs a private or public company?
Dr Lal PathLabs is a Public company.
-
What is Dr Lal PathLabs’s stock symbol?
The ticker symbol for Dr Lal PathLabs is LALPATHLAB.
-
What is the current stock price of Dr Lal PathLabs?
As of 16-Nov-2026 the stock price of Dr Lal PathLabs is $21.23.
-
What is the current market cap of Dr Lal PathLabs?
The current market capitalization of Dr Lal PathLabs is $3.55B.
-
What is Dr Lal PathLabs’s current revenue?
The trailing twelve month revenue for Dr Lal PathLabs is $327M.
-
Who are Dr Lal PathLabs’s competitors?
Metropolis Healthcare, Thyrocare Technologies, Oncquest, Prognosis Laboratories, and Aspira Pathlab & Diagnostics are some of the 10 competitors of Dr Lal PathLabs.
-
What is Dr Lal PathLabs’s annual earnings per share (EPS)?
Dr Lal PathLabs’s EPS for 12 months was $0.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process